Biotechnology from bench to business

• Follow GEN on:
• Login | Register | Subscribe

• ADME/Tox
• Automation
• Bioprocess Scale-Up
• Bioreactors
• Biosimilars
• Cell Culture
• Cell-Based Assays
• Contract Manufacturing
• Gene Therapy
• High-Throughput Screening
• Immunoassay
• Induced Pluripotent Stem Cells
• Informatics
• Liquid Handling
• Protein Characterization
• Protein Detection
• Regenerative Medicine
• RNAi/siRNA
• Stem Cells
• Western Blot

• GEN Articles

• More »

• BioMarket Trends: Ten Predictions that Will Transform Healthcare
  Trends Likely to Reshape Biotech in the Coming Years
• Assay Tutorials: Differentiating Mitochondrial Toxicity
  New Assay Chemistry Can Identify the Type of Mechanistic Toxicity and Help Reduce Drug Failures

• Insight & Intelligence™

• More »

• 10 Predictions That Will Transform Healthcare
  January 22, 2013
  Peer into GEN's crystal ball for a glimpse of what's to come.

• GEN News Highlights

• More »

• Edison Will Receive Up To $525M in Mitochondrial and CNS Disease Deal
  
• How Aggressive Breast Tumors and Mitochondrial Mutations Are Linked
  
• Designer Babies Debate Heats Up
  
• FDA Clears Expanded Access Program for Edison’s Mitochondrial Diseases Candidate
  
• Investigators Identify Glutathione as a Marker for Mitochondrial Disorders
  

• GEN Podcasts

• More »

• MITOCHONDRIAL GENE DEFECTS AND DISORDERS
  - Interview with Marni J. Falk, M.D., Assistant Professor of Pediatrics, Division of Human Genetics, The Children's Hospital of Philadelphia

• New Products

• More »

INDIGO Biosciences Mitochondrial Toxicity Assays A new series of assays called the MitoVir platform evaluate mitochondrial toxicity by examining inhibition of the ribonucleoside triphosphates that are substrates for the human mitochondrial RNA polymerase (POLRMT). The MitoVir platform is based on